Niche Focus PercSys targets endourology kidney stone procedures with minimally invasive devices and a pipeline expanding toward in-office interventions, presenting a focused opportunity to sell to urology clinics and ambulatory surgery centers seeking less traumatic stone treatment options.

Small but Nimble With a lean team and $4.8M in funding, PercSys can be approached as a rapid-buying decision maker, offering flexible pilots, quick ROI demonstrations, and streamlined procurement processes suited to small medical device manufacturers.

Clinical Expansion Product development toward external and in-office stone interventions opens cross-sell opportunities in outpatient settings and partnerships with hospitals expanding their minimally invasive stone programs.

Strategic Partnerships Comparable industry peers are large, but similar companies show value in collaborating with regional distributors, teaching sites, and integrated care networks; identify channels for co-marketing, training, and bundled service offerings.

Digital Footprint PercSys relies on Cloudflare infrastructure and web tools; leverage digital outreach, search visibility, and content marketing to educate prospects in urology groups, device committees, and procurement teams about procedural improvements.